Comparative effectiveness of β-blockers in elderly patients with heart failure

Archives of Internal Medicine

Volumn 168, Issue 22, 2008, Pages 2422-2428

  Kramer, Judith M ^a,b,e   Curtis, Lesley H ^a,b   Dupree, Carla S ^c,d   Pelter, David ^d   Hernandez, Adrian ^a,b   Massing, Mark ^d   Anstrom, Kevin J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Carolinas Center for Medical Excellence   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL FUMARATE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL SUCCINATE; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GERIATRIC PATIENT; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PHARMACY; PRIORITY JOURNAL; PROBABILITY; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 58149094800     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2008.511     Document Type: Article

References (24)

1. Packer M, Bristow MR, Cohn JN, et al; U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334(21):1349-1355.
2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001-2007.
3. Hjalmarson A, Goldstein S, Fagerberg B, et al; MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA. 2000;283(10):1295-1302.
4. Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). A randomised trial. Lancet. 1999;353(9146):9-13.
5. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46(6):e1-e82.
6. Lunceford JK, Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med. 2004;23(19):2937-2960.
7. Bang H, Tsiatis AA. Estimating medical costs with censored data. Biometrika. 2000;87:329-343.
8. Anstrom KJ, Tsiatis AA. Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data. Biometrics. 2001;57(4):1207-1218.
9. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care. 2007;45(10)(suppl 2):S103-S107.
10. Zhao Y, Ash AS, Ellis RP, Slaughter JP. Disease burden profiles: an emerging tool for managing managed care. Health Care Manag Sci. 2002;5(3):211-219.
11. Ash AS, Posner MA, Speckman J, Franco S, Yacht AC, Bramwell L. Using claims data to examine mortality trends following hospitalization for heart attack in Medicare. Health Serv Res. 2003;38(5):1253-1262.
12. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139.
13. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care. 2005;43(5):480-485.
14. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7-13.
15. McBride BF, White CM. Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET. J Clin Pharmacol. 2005;45(1):6-24.
16. Fonarow GC, Abraham WT, Albert NM, et al. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2007;153(1):82.e1-e11.
17. Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure. Am J Cardiol. 2007;100(4):690-696.
18. Smith NL, Chan JD, Rea TD, et al. Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure. Am Heart J. 2004;148(4):710-717.
19. Kramer JM, Chen AY, Hammill BG, et al. Time trends and factors associated with outpatient beta-blocker use in patients with heart failure or left ventricular dysfunction. Circulation. 2004;109:e231-e284.
20. Lee DS, Tu JV, Juurlink DN, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294(10):1240-1247.
21. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure: a Bayesian meta-analysis. Ann Intern Med. 2001;134(7):550-560.
22. Whellan DJ, Gaulden L, Gattis WA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001;161(18):2223-2228.
23. Whellan DJ, Hasselblad V, Peterson E, O'Connor CM, Schulman KA. Meta-analysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J. 2005;149(4):722-729.
24. Galbreath AD, Krasuski RA, Smith B, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation. 2004;110(23):3518-3526.